Peripheral Angioplasty Market is predicted to reach USD 7.1 billion at a CAGR of 7.90% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Peripheral Angioplasty Market”.

The Peripheral Angioplasty market is estimated to register a CAGR of 7.90% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global Peripheral Angioplasty market— Boston Scientific Corporation, Medtronic, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, Cook Medical, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Becton, Dickinson and Company, MicroPort Scientific, Corporation, eleflex Incorporated, W. L. Gore & Associates, Biotronik SE & Co. KG, AngioDynamics, Inc.

Access full report @ https://www.marketresearchfuture.com/reports/peripheral-angioplasty-market-16133

Market Highlights

The global Peripheral Angioplasty market is accounted to register a CAGR of 7.90% during the forecast period and is estimated to reach USD 7.1 billion by 2032.

Compared to open surgery, peripheral angioplasty involves less intrusive techniques. Shorter hospital stays, less discomfort during surgery, quicker recovery, and a decreased chance of complications are just a few advantages. Peripheral angioplasty operations can be expensive, both in terms of the accompanying hospital fees and the devices utilized. Research organizations, healthcare organizations, and producers of medical devices can work together to promote innovation and raise the standard of peripheral angioplasty treatments.

Segment Analysis

The global Peripheral Angioplasty market has been segmented based product and end user.

On the basis of product, the market is segmented into Balloon Catheters, Stents and Guide wires. The Balloon Catheters segment was attributed to holding the largest market share in 2022.Due to the effectiveness of balloon catheters in achieving vessel dilation.

Based on end user, the global Peripheral Angioplasty market has been segmented into Hospitals, Ambulatory Surgical Centres and Cardiac Catheterization Centres. The hospitals segment was expected to hold the largest market share in 2022. Because hospitals are the primary locations for providing full medical care and treatments

Regional Analysis

The global Peripheral Angioplasty market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Peripheral Angioplasty market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Peripheral Angioplasty market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Peripheral Angioplasty market comprises of Middle East, Africa, and Latin America.

The largest market share for Peripheral Angioplasty was maintained by the North American regional sector. The strong healthcare system and greater healthcare spending in North America have a major positive impact on the peripheral angioplasty market's expansion. The number of treatments carried out rises with increased insurance coverage and accessibility to healthcare facilities. More people are seeking medical attention as a result of increased awareness campaigns about PAD, its risk factors, and accessible treatment choices. Market increase is driven by awareness campaigns run by pharmaceutical corporations and healthcare groups.

Moreover, the Europe market has been persistently growing over the forecast period. The demand for Peripheral Angioplasty is driven by patient advocacy groups, healthcare organizations, and medical professionals are essential in educating the public about peripheral angioplasty (PAD), its risk factors, and available treatment options. As a result, PAD is becoming more and more in demand in Europe.

Additionally, over the projection period, Asia Pacific is expected to expand at the quickest rate due to the rising frequency of diabetes, which in turn causes an increase in the incidence of peripheral vascular illnesses. In addition, a number of variables that are anticipated to drive the market in the approaching years include the rising need for minimally invasive treatments, technologically sophisticated treatments, and improved healthcare infrastructure.

Furthermore, the rest of the world's Peripheral Angioplasty market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the region's rising use of number of treatments carried out rises with increased insurance coverage. Government support, a rise in investor interest, and the viability of the technology in the sector are all contributing factors to the market expansion.

Key Findings of the Study

• The global Peripheral Angioplasty market is expected to reach USD 7.1 billion by 2032, at a CAGR of 7.90% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the increasing frequency of diabetes, which in turn causes an increase in the incidence of peripheral vascular illnesses.


• Based on end user, the hospitals segment was expected to hold the largest market share in 2022.


• Boston Scientific Corporation, Medtronic, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, Cook Medical, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Becton, Dickinson and Company, MicroPort Scientific, Corporation, eleflex Incorporated, W. L. Gore & Associates, Biotronik SE & Co. KG, AngioDynamics, Inc.